The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.20
Ask: 1.30
Change: -0.10 (-7.41%)
Spread: 0.10 (8.333%)
Open: 1.35
High: 1.35
Low: 1.225
Prev. Close: 1.35
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 hits record high on BoE vote, UK GDP

Fri, 10th May 2024 12:00

(Alliance News) - Stock prices in London were up at midday on Friday, hitting a record high once again as investors reacted positively to a dovish Bank of England interest rates hold.

Meanwhile, UK gross domestic product data came out before the opening, showing growth above expectations in March and across the first quarter, with the UK officially coming out of a technical recession.

The FTSE 100 index was up 66.70 points, 0.8%, at 8,448.05, after hitting a record high 8,455.77 earlier. The FTSE 250 was up 163.86 points, 0.8%, at 20,695.16, and the AIM All-Share was up 5.05 points, 0.6%, at 788.75.

The Cboe UK 100 was up 0.9% at 844.75, the Cboe UK 250 was up 0.9% at 17,973.70, and the Cboe Small Companies was up 0.3% at 16,089.25.

In European equities on Friday, the CAC 40 in Paris was up 0.9%, while the DAX 40 in Frankfurt was 0.7%.

"The FTSE 100 is again in the ascendancy as the market hit new all-time highs on Friday. Given its international horizons, this has little to do with the UK's better-than-expected GDP growth and is largely being driven by strength in the resources space where higher metals prices and the promise of M&A are helping to stoke share prices," said AJ Bell analyst Russ Mould.

"The next key test of the index's new-found vim and vigour will likely come next week in the form of US inflation figures. Investors have broadly accepted rate cuts won't be as deep or come as soon as would have been anticipated at the start of the year. However, any signs inflation is proving much more stubborn than predicted would still represent a shock to the system for financial markets."

US producer price inflation figures come out on Tuesday next week at 1330 BST, followed by consumer price inflation data at the same time on Wednesday next week.

Stocks in New York were called higher. The Dow Jones Industrial Average was called up 0.3%, the S&P 500 index up 0.3%, and the Nasdaq Composite up 0.4%.

At its May meeting, the Bank of England's Monetary Policy Committee voted by a majority of 7 to 2 to maintain bank rate at 5.25%. Two members preferred to reduce the bank rate by 0.25 percentage points, to 5.00%.

Seven members, Bank of England Governor Andrew Bailey, Sarah Breeden, Ben Broadbent, Megan Greene, Jonathan Haskel, Catherine Mann and Huw Pill, voted in favour of the status quo.

Swati Dhingra and BoE Deputy Governor Dave Ramsden voted for a cut.

The UK economy grew ahead of expectations in March and in the first quarter of 2024, according to numbers on Friday.

According to the Office for National Statistics, UK gross domestic product rose by 0.4% in March from February, ahead of FXStreet cited consensus of 0.1% growth. UK GDP had expanded 0.2% on-month in February, according to revised data.

In the first quarter of 2024, GDP is estimated to have risen 0.6%, beating expectations of a 0.4% rise and following a 0.3% decline in the fourth quarter of 2023 and a 0.1% decline in the third quarter. Compared with the same quarter a year ago, GDP rose 0.2%.

"The UK has charged out of what will go down in the history books as the shortest, shallowest recession on record. After months of floundering around a flatline, growth of 0.6% will give the UK economy a real confidence boost. Services and manufacturing have helped offset ongoing challenges being faced by the construction sector," said AJ Bell analyst Danni Hewson.

"Falling inflation and rising wages have given households a bit more in the tank and they've upped their spend, something that will need to continue if the trajectory is to be maintained. Andrew Bailey painted a bucolic picture of a recovering economy which will be further boosted by any rate cut tailwinds. But the resilience being demonstrated by most sectors could be seen as a reason for MPC members to keep their finger on the pause button for a little while longer."

Sterling was quoted at USD1.2532 at midday on Friday, higher than USD1.2511 at the London equities close on Thursday.

The euro traded at USD1.0780 at midday on Friday, up from USD1.0775 late Thursday. Against the yen, the dollar was quoted at JPY155.74 versus JPY155.61.

In the FTSE 100, miners were among the best performing stocks, with Glencore up 3.3%, Anglo American up 2.0% and Antofagasta up 1.9%.

Gold was quoted at USD2,376.77 an ounce at midday on Friday, higher than USD2,332.88 on Thursday.

British Airways owner IAG rose 0.6%, after it said revenue in the first quarter of 2024 rose to EUR6.43 billion from EUR5.89 billion a year earlier.

Operating profit multiplied to EUR68 million from EUR9 million, while pretax loss narrowed to EUR87 million from EUR121 million.

"Our group benefits from the strength of our core markets - North Atlantic, South Atlantic and intra-Europe - and the performance of our brands. Investment across the group in transformation is delivering encouraging improvements in punctuality and customer experience at our airlines," said Chief Executive Officer Luis Gallego.

"We are well-positioned for the summer. The high demand for travel is a continuing trend. IAG expects non-fuel costs to increase slightly in 2024, reflecting investment. Net debt on March 31 stood at EUR7.44 billion, down from EUR9.25 billion a year earlier."

In the FTSE 250, TBC Bank rose 4.2%.

The Tbilisi, Georgia-based lender announced a share buyback programme of up to GEL75 million or GBP22.4 million, after it reported pretax profit in the first quarter of 2024 rose to GEL343.2 million, or GBP102.3 million, from GEL296.3 million a year earlier.

Total operating income rose to GEL618.0 million from GEL532.2 million, with net interest income up to GEL442.8 million from GEL366.8 million, net fee and commission income up to GEL104.3 million from GEL92.4 million, while other non-interest income ticked down to GEL70.8 million from GEL73.0 million.

TBC Bank's total customer base at March 31 rose to 17.9 million from 13.3 million a year earlier.

Looking ahead, Chief Executive Officer Vakhtang Butskhrikidze commented: "I believe that the group is well positioned to build further on this strong start to the year and deliver excellent results for our shareholders in 2024, as well as ensuring we are on track to meet our strategic targets for next year.

Among London's small-caps, TT Electronics lost 7.7%. In the four months ended April 30, the electronic component manufacturer said revenue falls 2% on an organic basis from a year earlier, but up 1% excluding the impact of pass-through revenues, which it said continue to reduce.

Looking ahead, Chief Executive Officer Peter France commented: "Whilst there is continuing global macro-economic uncertainty, the outlook for our markets remains good. The significant orderbook coverage and our prompt actions across the business underpin the board's confidence in an unchanged outlook for the year and the delivery of the 10% operating margin target."

On AIM in London, Polarean Imaging gained 36%. The medical imaging technology developer said it received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital.

It expects to install the new system later this year and will collaborate "closely" with the hospital team, as it does with its existing clinical sites, to develop a "strong" Xenon MRI programme.

Polarean Imaging said this programme will support clinical imaging, NIH-funded research, and pharmaceutical-sponsored trials, aligning with Polarean's commitment to advancing medical research and patient care.

Brent oil was trading at USD84.42 a barrel at midday on Friday, higher than USD83.62 late Thursday.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
22 May 2024 21:05

TRADING UPDATES: Powerhouse resolves claim; PCI-PAL wins court case

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
21 May 2024 20:23

Polarean Imaging to raise USD10 million via placing and subscription

(Alliance News) - Polarean Imaging PLC on Tuesday said that it intends to raise a minimum of USD10 million via a placing to institutional and other investors, and a direct subscription with the company.

Read more
10 May 2024 11:57

Polarean shares jump on MRI system order

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging shares were surging on Friday, after receiving its second de novo order for a new Xenon MRI System from the University of Alabama at Birmingham (UAB) Hospital.

Read more
10 May 2024 11:40

Polarean shares soar on University of Alabama deal for Xenon MRI

(Alliance News) - Polarean Imaging PLC on Friday said it has received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital in the US.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 15:40

IN BRIEF: Polarean Imaging wins order for new polariser

Polarean Imaging PLC - London-based medical imaging technology developer - Receives an order for a new polariser to replace the research polariser at Cincinnati Children's Hospital Medical Center. "Cincinnati Children's previously purchased the first clinical polariser and continues to demonstrate a commitment to the future of Xenon MRI for challenging lung diseases. Cincinnati Children's performs hospital clinical imaging on both children and adults (from their neighbouring partner institution, UC Medical Centre)," Polarean says.

Read more
3 May 2024 11:46

Polarean gets new polariser order from Cincinnati Children's

(Sharecast News) - Polarean Imaging announced a new polariser order to replace the research polariser at Cincinnati Children's Hospital Medical Center on Friday.

Read more
16 Apr 2024 20:16

TRADING UPDATES: Nexteq confident of meeting full-year expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:28

Polarean Imaging shares sink after announcing a costly strategic plan

(Alliance News) - Polarean Imaging PLC shares dropped on Thursday, after the company said it would need to find an additional USD10 million to finance its medium-term ambitions.

Read more
15 Jan 2024 11:21

IN BRIEF: Polarean Imaging strategic parter raises stake to above 10%

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price.

Read more
7 Dec 2023 16:01

Polarean gets first de novo order for Xenoview polariser

(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.

Read more
7 Dec 2023 12:14

IN BRIEF: Polarean shares jump on Xenoview polariser order

Polarean Imaging PLC - London-based medical imaging technology developer - Receives its first de novo order for a new Xenoview polariser from an unnamed "top-tier" academic medical centre located in the northeast of the US. Polarean says it continues to have positive meetings and is in active negotiations with additional academic medical centres. Xenoview is a hyperpolarised contrast agent for use with magnetic imaging for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. It was approved for use in the US last year.

Read more
7 Dec 2023 11:11

AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
8 Sep 2023 14:12

Polarean Imaging enters strategic partnership with VIDA Diagnostics

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.